phosphorylcholine and amphotericin b

phosphorylcholine has been researched along with amphotericin b in 163 studies

Research

Studies (163)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	44 (26.99)	29.6817
2010's	94 (57.67)	24.3611
2020's	25 (15.34)	2.80

Authors

Authors	Studies
Murray , HW	1
Croft, SL; Escobar, P; Yardley, V	1
Sundar, S	1
Croft, SL; Escobar, P; Marques, C; Matu, S	1
Marty, P; Rosenthal, E	2
Berman, J; Bryceson, A; Engel, J; Fischer, C; Jha, TK; Junge, K; Sindermann, H; Sundar, S; Thakur, CP	1
Roca, B	1
Carter, KC; Mullen, AB; Pereira, OC; Spickett, C; Sundar, S	1
Berman, J	1
Garnier, JM; Minodier, P; Retornaz, K; Robert, S	1
Hepburn, NC	1
Murray, HW	3
Singh, S; Sivakumar, R	1
Bandyopadhyay, S; Chatterjee, M; Dutta, A; Mandal, C	1
Dube, A; Singh, N; Sundar, S	1
Kumar, A; Sundar, S	1
Bange, FC; Rihl, M; Schmidt, RE; Stoll, M; Ulbricht, K	1
Bandyopadhyay, S; Chatterjee, M; Ganguly, S; Sarkar, A	1
Croft, SL; Seifert, K	1
Bhattacharya, SK; Karbwang, J; Sur, D	1
Jha, TK	1
Croft, SL; Seifert, K; Yardley, V	1
Barratt, G; Besnard, M; Buyse, M; Farinotti, R; Loiseau, PM; Ménez, C	1
Jayswal, BP; Mishra, OP; Prasad, R; Singh, UK	1
Boelaert, M; Diap, G; Gerstl, S; Guerin, PJ; Meheus, F; Van der Stuyft, P; Vanlerberghe, V	1
Minodier, P; Parola, P	1
Blanc, P; Garnier, JM; Minodier, P; Noël, G; Retornaz, K; Uters, M	1
Boucher, P; Hadighi, R; Khamesipour, A; Meamar, AR; Mohebali, M; Ouellette, M; Roy, G	1
Ayres, DC; Giorgio, S; Pinto, LA	1
Im, KI; Jung, SY; Kim, JH; Kim, K; Kwon, D; Lee, YJ; Park, S; Shin, HJ; Song, KJ	1
Agarwal, D; Agrawal, N; Chakravarty, J; Murray, HW; Olliaro, P; Rai, M; Sundar, S; Vaillant, M	1
Alborzi, A; Fakhar, M; Hatam, GR; Kadivar, MR; Motazedian, MH; Pouladfar, GR	1
Bestetti, A; Bossolasco, S; Cernuschi, M; Cinque, P; De Bona, A; Gaiera, G; Gianotti, N; Lazzarin, A; Maillard, M	1
Bossolasco, S; Ceserani, N; Cinque, P; Gaiera, G; Gianotti, N; Guffanti, M; Lazzarin, A; Ratti, D; Salmaso, F	1
Kulshrestha, A; Kumar, D; Salotra, P; Singh, R	1
Olliaro, P; Sundar, S	1
Beck, JC; Berman, J; Davidson, C; Mings, S; Ondo, AL; Shanler, SD	1
Bimal, S; Das, P; Das, VN; Lal, CS; Pandey, K; Siddiqui, NA; Singh, D; Topno, RK; Verma, N; Verma, RB	1
Meenakshi Thakur, AK; Thakur, CP; Thakur, S	1
Clement, JG; Gershkovich, P; Thornton, SJ; Tidwell, RR; Wasan, EK; Wasan, KM; Werbovetz, KA; Zhu, X	1
Cos, P; da Luz, RI; Maes, L; Timmermans, JP; Toté, K; Vermeersch, M	1
Darley, S; Laxminarayan, R; Olliaro, P; Sundar, S	1
Kumar, D; Ramam, M; Ramesh, V; Salotra, P; Verma, S	1
Alvar, J; Balasegaram, M; Boelaert, M; Lynen, L; Meheus, F; van Griensven, J	1
Liarte, DB; Murta, SM	1
Duncan, RC; Kumar, D; Nakhasi, HL; Salotra, P; Singh, R	1
Badaro, R; Chang, KP; Day, J; Mehta, SR; Schooley, RT; Spina, C; Zhang, XQ	1
Ali, N; Bhattacharya, P; Mondal, S	1
Balasegaram, M; Boelaert, M; Faiz, MA; Meheus, F; Olliaro, P; Rijal, S; Sundar, S	1
Olliaro, PL	1
Palumbo, E	1
Alam, S; Arana, B; Berman, J; Chakravarty, J; Ghalib, H; Kumar, N; Kumari, P; Pandey, K; Ravidas, V; Sinha, PK; Sundar, S; Verma, DK; Verma, N	1
Fedorko, DP; Mahanty, S; Nash, TE; Ramanathan, R; Talaat, KR	1
Alam, S; Arora, R; Balasegaram, M; Chakravarty, J; Das, P; Ellis, S; Kumari, P; Lal, CS; Modabber, F; Nawin, K; Olliaro, P; Pandey, K; Rai, M; Sharma, B; Sinha, PK; Strub-Wourgaft, N; Sundar, S; Vaillant, M; Verma, DK; Verma, N	1
Boelaert, M; van Griensven, J	1
Alvar, J; Arana, B; Battacharya, S; Das, P; Kroeger, A; Matlashewski, G; Mondal, D; Rijal, S; Sinha, PK; Sundar, S; Zilberstein, D	1
Hanus, I; Harms, G; Häussinger, D; Löscher, T; Richter, J	1
Abuzaid, AA; Alexander, N; Balasegaram, M; Dorlo, TP; Edwards, T; Ellis, S; Khalil, EA; Kinoti, D; Kirigi, G; Musa, AM; Njoroge, N; Omollo, R; Wasunna, M; Younis, BM	1
Das, P; Kumar, N; Lal, CS; Pandey, K; Ranjan, A; Sinha, PK; Verma, N; Verma, RB	1
Leprohon, P; Moreira, W; Ouellette, M	1
Harms, G; Reiter-Owona, I; Richter, J; Scherbaum, H; Stich, A	1
Bories, C; Cojean, S; Haouchine, D; Houzé, S; Hubert, V; Huteau, F; Lariven, S; Le Bras, J; Loiseau, PM; Matheron, S; Michard, F; Pratlong, F	1
Bastien, P; Bendix, K; Christensen, M; d'Amore, F; Hellberg, YK; Larsen, CS; Petersen, E; Ravel, C; Schaumburg, H; Vase, MØ	1
Kumar, M; Singh, N; Singh, RK	1
Aguiar, MG; Carneiro, G; Fernandes, AP; Ferreira, LA	1
Bocanegra, R; Kirkpatrick, WR; Najvar, LK; Patterson, TF; Sorrell, TC; Wiederhold, NP	1
Pandey, K; Pun, SB; Shah, R	1
Chakravarty, J; Sundar, S	1
Bastin, P; Blisnick, T; Foucher, AL; Gharbi, S; Pemberton, IK; Rachidi, N; Späth, GF	1
Abebe, T; Hailu, A; Kassahun, A; Utaile, M	1
Barratt, G; Loiseau, PM; Michel, JP; Pham, TT; Saint-Pierre-Chazalet, M	1
Boelaert, M; Dujardin, JC; Hasker, E; Malaviya, P; Ostyn, B; Rijal, S; Singh, RP; Sundar, S; Uranw, S	1
Bogdan, C; Debus, A; Ehrchen, J; Eichner, S; Harms, G; Herrgott, I; Sebald, H; Simon, M; Sunderkötter, C; Thoma-Uszynski, S; Tsianakas, A	1
Agarwal, N; Arya, SC	1
Campino, L; Henriques, S; Maia, C; Marques, M; Nunes, M; Rolão, N	1
Antoniou, M; Christodoulou, V; Koutala, E; Mazeris, A; Messaritakis, I; Papadogiorgaki, S; Vlahou, A	1
Avishek, K; Ramesh, V; Salotra, P; Sharma, V	1
Mesquita, JT; Reimão, JQ; Tempone, AG	1
Burza, S; Patole, S; Varghese, GM	1
Abreu, S; Barratt, G; Chaminade, P; Cheron, M; Gueutin, C; Loiseau, PM; Pham, TT	1
Boelaert, M; Diro, E; Hailu, A; Lynen, L; Ritmeijer, K; van Griensven, J	1
Chatterjee, M; Singh, N; Sundar, S	1
Bell, AS; Heal, WP; Hutton, JA; Leatherbarrow, RJ; Paape, D; Smith, DF; Tate, EW	1
Botterel, F; Bougnoux, ME; Compain, F; Dannaoui, E; Paugam, A; Sitterlé, E	1
Borba-Santos, LP; de Souza, W; Gagini, T; Ishida, K; Rozental, S	1
Boelaert, M; Burza, S; Das, P; Isaakidis, P; Kumar, D; Lima, MA; Mahajan, R; Mitra, G; Pandey, K; Sagili, KD; Sunyoto, T; Van Geertruyden, JP	1
Cappel, MA; Keeling, JH; Kevric, I	1
Chatterjee, M; Das, NK; Ghosh, S; Mukherjee, S; Mukhopadhyay, D; Roy, S; Saha, B	1
Chandrakar, P; Kar, S; Parmar, N; Vishwakarma, P; Yadav, PK	1
Bhattacharya, SK; Dash, AP	1
Dunn, AL; Levy, RA; Reed, T; Stewart, C	1
Aguilar, F; Cantizani, J; Coteron, JM; Croft, SL; Díaz, R; Martin, JJ; Peña, I; Presa, JL; Tegazzini, D; Yardley, V	1
Coelho, AC; Espada, CR; Oliveira, JC; Reimão, JQ; Trinconi, CT; Uliana, SR	1
Alexander, N; Ali, MH; Alves, F; Balasegaram, M; Dorlo, TP; Edwards, T; Elamin, MY; Ellis, S; Hailu, A; Juma, R; Khalil, EA; Kimutai, R; Kip, AE; Kirigi, G; Musa, A; Musa, B; Njenga, S; Olobo, J; Omollo, R; Schoone, GJ; Strub Wourgaft, N; Wasunna, M; Wells, S	1
Boelaert, M; Hasker, E; Singh, OP; Sundar, S	1
Aguado, JM; Alonso-Moralejo, R; Andrés, A; Carrasco-Antón, N; Fernández-Ruiz, M; González, E; López-Medrano, F; Pérez-Jacoiste Asín, MA; San Juan, R	1
Caljon, G; Croft, SL; Guerin, PJ; Hendrickx, S; Maes, L	1
Brotherton, MC; Fernandez-Prada, C; Leprohon, P; Ouellette, M; Rivas, L; Roberts, M; Roy, G; Smith, TK; Vincent, IM	1
Ali, I; Babik, JM; Brondfield, MN; Cope, JR; DeMarco, T; Doernberg, SB; Hilts-Horeczko, A; Klein, L; Matanock, A; Reid, MJ; Ritter, JM; Rutishauser, RL; Tang, J	1
Amer, A; Asal, AM; Bekhit, AA; El-Faham, A; Guemei, AA; Haiba, NS; Khattab, SN	1
Esposito, S; Pagliano, P	1
Cantizani, J; Coterón, JM; Martín, J; Peña, I; Tegazzini, D	1
Alvar, J; Alves, F; Balasegaram, M; Boer, MD; Ellis, S; Faiz, A; Goyal, V; Haque, R; Jamil, K; Rahman, R; Rijal, S; Samad, R; Sharma, B; Strub-Wourgaft, N	1
Croft, SL; Murdan, S; Van Bocxlaer, K; Wijnant, GJ; Yardley, V	1
Arrese Estrada, J; Cnops, L; Darcis, G; de Leval, L; Giot, JB; Hayette, MP; Leonard, P; Moutschen, M; Tassin, F; Van der Auwera, G	1
Dube, A; Jaiswal, AK; Mishra, PR; Tripathi, P	1
de Paula, E; Giorgio, S; Ortega, V	1
Chatterjee, M; Chaudhuri, SJ; Das, NK; Ghosh, M; Moulik, S; Saha, B; Sardar, B	1
Al-Shargabi, TQ; Atta, KFM; Bekhit, AA; El Ashry, ESH; Farahat, OOM; Ibrahim, TM; Marei, MG	1
Fernando, SD; Rajapakse, S; Rodrigo, C; Weeratunga, P	1
Caljon, G; Hendrickx, S; Maes, L; Mondelaers, A; Van Bockstal, L	1
Bolás-Fernández, F; Castillo, R; Dea-Ayuela, MA; Hernández-Campos, A; Maldonado-Rangel, A; Matius-Ruiz, JB; Méndez-Cuesta, C; Nieto-Meneses, R; Nogueda-Torres, B; Trejo-Soto, PJ; Yépez-Mulia, L	1
Singh, A; Sundar, S	1
Barrett, MP; Dujardin, JC; Gamarro, F; García-Hernández, R; López-Vélez, R; Mwenechanya, R; Papadopoulou, B; Ponte-Sucre, A; Pountain, AW	1
Agarwal, D; Sundar, S	1
Hamzavi, SS; Kadivar, MR; Pouladfar, G; Pourabbas, B; Sanaei Dashti, A	1
Das, P; Vijayakumar, S	1
Croft, SL; Harris, A; Seifert, K; Sepúlveda, N; Standing, JF; Voak, AA	1
Bresson, E; Fernandez-Prada, C; Leprohon, P; Ouellette, M; Plourde, M; Roy, G; Sharma, M	1
Arvelo, F; Benaim, G; Dagger, F; Kouznetsov, VV; Mejías, F; Rojas-Ruiz, FA; Sojo, F; Torrealba, C; Valdivieso, E	1
Das, S; Halder, A; Mukherjee, A; Roy, P; Saha, B; Shukla, D	1
Abongomera, C; Ahmed, F; Buyze, J; de Lima Pereira, A; Diro, E; Ritmeijer, K; Stille, K; van Griensven, J	1
Ishida, K; Rozental, S; Spadari, CC; Vila, T	1
Carrillo, E; Mejías, F; Moreno, J; Sánchez, C; Valdivieso, E	1
Carrer, DC; Moody, D; Peralta, MF; Smith, H; Tristram-Nagle, S	1
Ahuja, V; Ghosh, P; Haque, R; Hossain, AFMA; Hossain, MA; Hossain, MS; Kumar, A; Mahshin, M; Maruf, S; Mondal, D; Shamsuzzaman, AKM; Sharma, A; Sharma, V	1
Caljon, G; Cos, P; Delputte, P; Gielis, JF; Hendrickx, S; Maes, L; Van Bockstal, L; Van den Kerkhof, M	1
Alvar, J; Alves, F; Balasegaram, M; Bern, C; Burza, S; Das, P; Ellis, S; Goyal, V; Hightower, A; Lima, N; Mahajan, R; Pandey, K; Rabi Das, VN; Rijal, S; Sharma, B; Singh, RS; Singh, SN; Strub-Wourgaft, N; Sunyoto, T; Topno, RK	1
Admassu, H; Alexander, N; Alvar, J; Alves, F; Bardonneau, C; Blesson, S; Diro, E; Edwards, T; Ellis, SJ; Fikre, H; Hailu, A; Kibret, A; Kimutai, R; Mutinda, B; Omollo, R; Omwalo, G; Ritmeijer, K; Soipei, P; Strub-Wourgaft, N; Tadesse, F; Wasunna, M; Zijlstra, EE	1
Alvar, J; Boelaert, M; Das, P; Mondal, D; Rijal, S; Sundar, S	1
Aouthmany, S; Cooper, AM; Rega, PP; Shah, K	1
Alsford, S; Baker, N; Collett, CF; Horn, D; Hutchinson, S; Kitson, C; Santrot, MV; Steele-Stallard, HB	1
Ainslie, KM; Bachelder, EM; Fuchs, JR; Johnson, MM; Satoskar, AR; Tokarski, RJ; Zahid, MSH	1
Braga, SS	1
Alvar, J; Alves, F; Bern, C; Burza, S; Das, P; Das, VNR; Goyal, V; Hightower, A; Lima, N; Pandey, K; Rijal, S; Singh, RS; Singh, SN; Strub-Wourgaft, N; Sunyoto, T	1
Dar, MJ; Khalid, S; Khan, GM; McElroy, CA; Satoskar, AR	1
Crone, CG; Helleberg, M	1
Memon, W; Totten, M; Wu, Y; Ying, C; Zhang, SX	1
Dixit, KK; Ramesh, V; Salotra, P; Sharma, N; Singh, R	1
Çavuş, İ; Harman, M; Kaya, T; Özbilgin, A; Yıldırım, A	1
Caplivski, D; Chai, RL; Eiras, DP; Kirkman, LA; Murray, HW	1
Adriaensen, W; Alves, F; Blesson, S; Cnops, L; Cordero, CF; Cuypers, B; Diro, E; Kaye, PM; Mengasha, B; van Griensven, J	1
Gedda, MR; Mudavath, SL; Parvez, S; Singh, A; Singh, OP; Sundar, S; Verma, A; Yadagiri, G	1
Akova, M; Elçin, G; Ergüven, S; Harxhi, A; İnkaya, AÇ; Jaiteh, MB; Kurtulan, O; Üner, A	1
Bhattacharyya, M; Bodhale, NP; Pai, K; Saha, B; Sundar, S	1
Alunda, JM; Cuquerella, M; Fontán-Matilla, E; Olías-Molero, AI	1
Ahronowitz, IZ; Kassardjian, AA; Kim, GH; Liang, TZ; Ochoa, MT; Rabi, S; Sattah, MV; Yim, KM	1
Angulo-Barturen, I; Coteron-Lopez, JM; Croft, SL; Ferrer-Bazaga, S; Harris, A; Seifert, K; Voak, AA	1
Li, SH; Liu, Y; Lu, L; Niu, YN; Yang, CY; Zhang, HW; Zhao, DY; Zhao, YL; Zhou, RM; Zhu, X	1
Alves, F; Brack, M; Dahal, P; Guerin, PJ; Halleux, CM; Hawryszkiewycz, A; Maguire, BJ; Ngu, R; Olliaro, PL; Rashan, S; Singh-Phulgenda, S; Stepniewska, K	1
Alonso, A; Alonso, L; Dorta, ML; Gomes, RS; Mendanha, SA	1
Bakhos, D; Desoubeaux, G; Lemaignen, A; Renard, L	1
Chatterjee, M; Sengupta, S	1
Campos, MP; Figueiredo, FB; Gonçalves, AS; Gonçalves, G; Medeiros, LCS	1
Alonso, A; Alonso, L; Kipnis, A; Pimenta, LKL	1
Alexander, N; Alves, F; Burza, S; Das, P; Das, VNR; de Lima Pereira, A; Gill, N; Goyal, V; Harshana, A; Kazmi, S; Kumar, D; Kumar, V; Lal, CS; Lasry, E; Mahajan, R; Pandey, K; Rewari, B; Rijal, S; Verma, N	1
Araújo, MS; Bartholomeu, DC; Borges, VM; Cardoso, CDA; Laurenti, MD; Monte-Neto, RLD; Moreira, POL; Nogueira, PM; Rêgo, FD; Reis, AB; Soares, RP	1
Coelho, AC; Coser, EM; Ferreira, BA; Lindoso, JAL; Saborito, C; Yamashiro-Kanashiro, EH	1
Benoit, D; Boelens, J; Delanghe, JR; Gadeyne, B; Himpe, J; Speeckaert, MM; Verbeke, F	1
Jariyapan, N; Junkum, A; Kongkaew, A; Mano, C; Siriyasatien, P; Tippawangkosol, P	1

Reviews

38 review(s) available for phosphorylcholine and amphotericin b

Article	Year
Treatment of visceral leishmaniasis (kala-azar): a decade of progress and future approaches. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2000, Volume: 4, Issue:3 Topics: Adult; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Child; Humans; Leishmania donovani; Leishmaniasis, Visceral; Mice; Paromomycin; Phosphorylcholine; Treatment Outcome	2000
Treatment of visceral leishmaniasis: a review of current treatment practices. Expert opinion on pharmacotherapy, 2002, Volume: 3, Issue:8 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Developing Countries; HIV Infections; Humans; Leishmaniasis, Visceral; Mice; Phosphorylcholine; World Health Organization	2002
Current treatment approaches to leishmaniasis. Current opinion in infectious diseases, 2003, Volume: 16, Issue:5 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Clinical Trials as Topic; Fluconazole; Humans; Leishmaniasis; Paromomycin; Pentamidine; Phosphorylcholine	2003
[Visceral leishmaniasis: new drugs]. Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2003, Volume: 10 Suppl 5 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2003
Cutaneous leishmaniasis: current and future management. Expert review of anti-infective therapy, 2003, Volume: 1, Issue:4 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Humans; Immunotherapy; Leishmania; Leishmaniasis, Cutaneous; Paromomycin; Phosphorylcholine	2003
Progress in the treatment of a neglected infectious disease: visceral leishmaniasis. Expert review of anti-infective therapy, 2004, Volume: 2, Issue:2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Costs; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphatidylcholines; Phosphatidylglycerols; Phosphorylcholine; Practice Guidelines as Topic	2004
Challenges and new discoveries in the treatment of leishmaniasis. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy, 2004, Volume: 10, Issue:6 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania; Leishmaniasis; Pentamidine; Phosphorylcholine; Psychodidae	2004
[Visceral leishmaniases]. La Revue du praticien, 2004, Dec-31, Volume: 54, Issue:20 Topics: Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Brazil; Child, Preschool; Dogs; Ethiopia; Europe; Humans; Incidence; India; Infant; Infant, Newborn; Leishmaniasis, Visceral; Phosphorylcholine; Prevalence; Time Factors; Zoonoses	2004
Childhood visceral leishmaniasis. The Indian journal of medical research, 2006, Volume: 123, Issue:3 Topics: Administration, Oral; Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Humans; Leishmania donovani; Leishmaniasis, Visceral; Phosphorylcholine; Psychodidae	2006
Drug unresponsiveness & combination therapy for kala-azar. The Indian journal of medical research, 2006, Volume: 123, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance; Humans; India; Leishmania; Leishmaniasis, Visceral; Phosphorylcholine	2006
Current scenario of drug development for leishmaniasis. The Indian journal of medical research, 2006, Volume: 123, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Design; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Models, Chemical; Paromomycin; Phosphorylcholine	2006
Cutaneous leishmaniasis treatment. Travel medicine and infectious disease, 2007, Volume: 5, Issue:3 Topics: Administration, Cutaneous; Administration, Oral; Aminoquinolines; Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Humans; Imiquimod; Injections, Intralesional; Injections, Intramuscular; Leishmaniasis, Cutaneous; Paromomycin; Pentamidine; Phosphorylcholine	2007
[Treatment of visceral leishmaniasis in children]. Medecine tropicale : revue du Corps de sante colonial, 2007, Volume: 67, Issue:1 Topics: Amphotericin B; Antimony; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2007
Combination therapy for visceral leishmaniasis. The Lancet. Infectious diseases, 2010, Volume: 10, Issue:3 Topics: Amphotericin B; Antiprotozoal Agents; Asia; Brazil; Cost-Benefit Analysis; Drug Therapy, Combination; Europe; Humans; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine; Safety; South Africa	2010
Current diagnosis and treatment of visceral leishmaniasis. Expert review of anti-infective therapy, 2010, Volume: 8, Issue:8 Topics: Amphotericin B; Animals; Antigens, Protozoan; Antiprotozoal Agents; Drug Therapy, Combination; Enzyme-Linked Immunosorbent Assay; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Protozoan Proteins; Recombinant Proteins	2010
Drug combinations for visceral leishmaniasis. Current opinion in infectious diseases, 2010, Volume: 23, Issue:6 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cost-Benefit Analysis; Drug Resistance; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Leishmaniasis, Visceral; Paromomycin; Phosphorylcholine	2010
Visceral leishmaniasis in children: a review. Minerva pediatrica, 2010, Volume: 62, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Child; Drug Resistance; Drug Therapy, Combination; Global Health; Humans; Italy; Leishmania; Leishmaniasis, Visceral; Phosphorylcholine; Treatment Outcome	2010
Visceral leishmaniasis: elimination with existing interventions. The Lancet. Infectious diseases, 2011, Volume: 11, Issue:4 Topics: Amphotericin B; Antiprotozoal Agents; Communicable Disease Control; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Paromomycin; Phosphorylcholine	2011
Leishmaniasis in the United States: treatment in 2012. The American journal of tropical medicine and hygiene, 2012, Volume: 86, Issue:3 Topics: Administration, Oral; Amphotericin B; Antiprotozoal Agents; Humans; Immunocompromised Host; Injections, Intravenous; Leishmaniasis; Phosphorylcholine; United States	2012
Leishmaniasis: current status of available drugs and new potential drug targets. Asian Pacific journal of tropical medicine, 2012, Volume: 5, Issue:6 Topics: Aminoquinolines; Amphotericin B; Antigens, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Caspase Inhibitors; Cyclin-Dependent Kinases; Drug Discovery; Enzyme Inhibitors; Folic Acid Antagonists; Humans; Leishmaniasis; Macrophages; Microbodies; Mitogen-Activated Protein Kinase Kinases; Paromomycin; Pentamidine; Phosphorylcholine; Polyamines; Protease Inhibitors; Sterols; Sulfhydryl Compounds; Topoisomerase Inhibitors	2012
Drug delivery systems for the topical treatment of cutaneous leishmaniasis. Expert opinion on drug delivery, 2012, Volume: 9, Issue:9 Topics: Administration, Cutaneous; Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Delivery Systems; Humans; Imiquimod; Leishmaniasis, Cutaneous; Naphthoquinones; Paromomycin; Phosphorylcholine; Skin Absorption	2012
Leishmaniasis: an update of current pharmacotherapy. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:1 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Therapy, Combination; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Species Specificity; Treatment Outcome	2013
Visceral Leishmaniasis and HIV coinfection in East Africa. PLoS neglected tropical diseases, 2014, Volume: 8, Issue:6 Topics: Africa, Eastern; Amphotericin B; Anti-Retroviral Agents; Antiprotozoal Agents; Coinfection; HIV Infections; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Prevalence	2014
New World and Old World Leishmania Infections: A Practical Review. Dermatologic clinics, 2015, Volume: 33, Issue:3 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Incidence; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmania tropica; Leishmaniasis, Diffuse Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Phosphorylcholine; Polymerase Chain Reaction; Travel	2015
Elimination of visceral leishmaniasis on the Indian subcontinent. The Lancet. Infectious diseases, 2016, Volume: 16, Issue:12 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Health Services Accessibility; Humans; India; Insect Control; Insect Vectors; Leishmaniasis, Visceral; Neglected Diseases; Phosphorylcholine; Psychodidae; Public Health	2016
Evaluating drug resistance in visceral leishmaniasis: the challenges. Parasitology, 2018, Volume: 145, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance, Multiple; Humans; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Parasitic Sensitivity Tests; Phosphorylcholine; Psychodidae; Recurrence	2018
Disseminated Acanthamoeba infection in a heart transplant recipient treated successfully with a miltefosine-containing regimen: Case report and review of the literature. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:2 Topics: Acanthamoeba; Amebiasis; Amebicides; Amphotericin B; Anti-Bacterial Agents; Antilymphocyte Serum; Biopsy; Cardiomyopathies; Drugs, Investigational; Endoscopy; Female; Fluconazole; Flucytosine; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Magnetic Resonance Imaging; Metacarpal Bones; Metronidazole; Middle Aged; Phosphorylcholine; Polymerase Chain Reaction; Radiography; Sinusitis; Skin	2017
Visceral leishmaniosis in immunocompromised host: an update and literature review. Journal of chemotherapy (Florence, Italy), 2017, Volume: 29, Issue:5 Topics: Amphotericin B; HIV Infections; Humans; Immunocompromised Host; Leishmaniasis, Visceral; Phosphorylcholine; Recurrence	2017
Liposomal formulations in the pharmacological treatment of leishmaniasis: a review. Journal of liposome research, 2017, Volume: 27, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Compounding; Drug Delivery Systems; Drug Liberation; Humans; Leishmaniasis; Liposomes; Nanoparticles; Paromomycin; Particle Size; Pentamidine; Phosphorylcholine; Surface Properties	2017
Amphotericin B for treatment of visceral leishmaniasis: systematic review and meta-analysis of prospective comparative clinical studies including dose-ranging studies. Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2018, Volume: 24, Issue:6 Topics: Amphotericin B; Antiprotozoal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Drug Compounding; Evidence-Based Medicine; Female; Humans; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Survival Analysis; Treatment Outcome	2018
Chemotherapeutics of visceral leishmaniasis: present and future developments. Parasitology, 2018, Volume: 145, Issue:4 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Clinical Trials as Topic; Drug Resistance, Multiple; Drug Therapy, Combination; HIV Infections; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Psychodidae; Sheep; South America; Treatment Outcome	2018
Drug resistance and treatment failure in leishmaniasis: A 21st century challenge. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:12 Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Drug Therapy, Combination; Humans; Leishmania; Leishmania donovani; Leishmaniasis; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Molecular Epidemiology; Phosphorylcholine; Treatment Failure	2017
Visceral Leishmaniasis-Optimum Treatment Options in Children. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:5 Topics: Amphotericin B; Antiprotozoal Agents; Child; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Phosphorylcholine	2018
Recent progress in drug targets and inhibitors towards combating leishmaniasis. Acta tropica, 2018, Volume: 181 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Resistance; Humans; Leishmaniasis; Phosphorylcholine	2018
Killer amoebas: Primary amoebic meningoencephalitis in a changing climate. JAAPA : official journal of the American Academy of Physician Assistants, 2019, Volume: 32, Issue:6 Topics: Amebicides; Aminoglycosides; Amphotericin B; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Antiparasitic Agents; Azithromycin; Central Nervous System Protozoal Infections; Climate Change; Dexamethasone; Early Diagnosis; Early Medical Intervention; Fluconazole; Geography; Glucocorticoids; Humans; Hypothermia, Induced; Macrolides; Naegleria fowleri; Phosphorylcholine; Rifampin; United States; Ventriculostomy	2019
Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing. European journal of medicinal chemistry, 2019, Dec-01, Volume: 183 Topics: Amphotericin B; Antifungal Agents; Drug Repositioning; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Leishmaniasis; Molecular Targeted Therapy; Phosphorylcholine; Sterol 14-Demethylase; Triazoles; Voriconazole	2019
Diffuse cutaneous leishmaniasis and HIV co-infection: A case report and review of the literature. Journal of cutaneous pathology, 2021, Volume: 48, Issue:6 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Darier Disease; Drug Therapy, Combination; HIV Infections; Humans; Infusions, Intravenous; Leishmaniasis, Diffuse Cutaneous; Male; Phosphorylcholine; Skin Diseases, Parasitic; Treatment Outcome; Trypanosoma cruzi	2021
Serious adverse events following treatment of visceral leishmaniasis: A systematic review and meta-analysis. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:3 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Humans; Leishmaniasis, Visceral; Phosphorylcholine	2021

Trials

12 trial(s) available for phosphorylcholine and amphotericin b

Article	Year
Oral miltefosine for Indian visceral leishmaniasis. The New England journal of medicine, 2002, Nov-28, Volume: 347, Issue:22 Topics: Administration, Oral; Adolescent; Adult; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; India; Infusions, Intravenous; Leishmania donovani; Leishmaniasis, Visceral; Male; Phosphorylcholine; Recurrence; Spleen	2002
Miltefosine in children with visceral leishmaniasis: a prospective, multicentric, cross-sectional study. Indian journal of pediatrics, 2006, Volume: 73, Issue:12 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cross-Sectional Studies; Drug Resistance; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Prospective Studies; Treatment Outcome	2006
New treatment approach in Indian visceral leishmaniasis: single-dose liposomal amphotericin B followed by short-course oral miltefosine. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Oct-15, Volume: 47, Issue:8 Topics: Adult; Amphotericin B; Drug Therapy, Combination; Female; Humans; India; Leishmaniasis, Visceral; Male; Phosphorylcholine; Treatment Outcome	2008
Comparison of short-course multidrug treatment with standard therapy for visceral leishmaniasis in India: an open-label, non-inferiority, randomised controlled trial. Lancet (London, England), 2011, Feb-05, Volume: 377, Issue:9764 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Creatinine; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Hemoglobins; Humans; India; Leishmaniasis, Visceral; Liver; Liver Function Tests; Male; Middle Aged; Paromomycin; Phosphorylcholine; Recurrence; Young Adult	2011
Safety and efficacy of miltefosine alone and in combination with sodium stibogluconate and liposomal amphotericin B for the treatment of primary visceral leishmaniasis in East Africa: study protocol for a randomized controlled trial. Trials, 2011, Jun-30, Volume: 12 Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Child; Drug Therapy, Combination; Humans; Kenya; Leishmaniasis, Visceral; Middle Aged; Phosphorylcholine; Research Design; Sudan; Time Factors; Treatment Outcome; Trypanocidal Agents; Young Adult	2011
Efficacy and Safety of AmBisome in Combination with Sodium Stibogluconate or Miltefosine and Miltefosine Monotherapy for African Visceral Leishmaniasis: Phase II Randomized Trial. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:9 Topics: Adolescent; Adult; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Child; Drug Therapy, Combination; Female; Humans; Kenya; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Parasite Load; Phosphorylcholine; Sudan; Treatment Outcome; Young Adult	2016
Safety and efficacy of short course combination regimens with AmBisome, miltefosine and paromomycin for the treatment of visceral leishmaniasis (VL) in Bangladesh. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:5 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Bangladesh; Child; Child, Preschool; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Paromomycin; Phosphorylcholine; Recurrence; Treatment Outcome; Young Adult	2017
Field safety and effectiveness of new visceral leishmaniasis treatment regimens within public health facilities in Bihar, India. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:10 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Paromomycin; Phosphorylcholine; Prospective Studies; Treatment Outcome; Young Adult	2018
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia. PLoS neglected tropical diseases, 2019, Volume: 13, Issue:1 Topics: Adult; Amphotericin B; Anti-Retroviral Agents; Antiprotozoal Agents; Coinfection; Drug Therapy, Combination; Ethiopia; Female; HIV Infections; Humans; Leishmania donovani; Leishmaniasis, Visceral; Male; Middle Aged; Parasite Load; Phosphorylcholine; Treatment Outcome; Young Adult	2019
Host transcriptomic signature as alternative test-of-cure in visceral leishmaniasis patients co-infected with HIV. EBioMedicine, 2020, Volume: 55 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Endoribonucleases; Female; Gene Expression Regulation; HIV; HIV Infections; Host-Pathogen Interactions; Humans; Interleukin-10; Leishmania donovani; Leishmaniasis, Visceral; Male; Phagosomes; Phosphorylcholine; Receptors, Histamine H4; Recurrence; Serine Proteases; Transcriptome; Treatment Failure	2020
IgG3 and IL10 are effective biomarkers for monitoring therapeutic effectiveness in Post Kala-Azar Dermal Leishmaniasis. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:11 Topics: Adolescent; Adult; Amphotericin B; Antibodies, Protozoan; Biomarkers; Drug Monitoring; Female; Humans; Immunoglobulin G; Interleukin-10; Leishmania donovani; Leishmaniasis, Visceral; Male; Phosphorylcholine; Young Adult	2021
AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2022, 10-12, Volume: 75, Issue:8 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Drug Therapy, Combination; HIV; HIV Infections; Humans; India; Leishmaniasis, Visceral; Pharmaceutical Preparations; Phosphorylcholine; Recurrence; Treatment Outcome	2022

Other Studies

113 other study(ies) available for phosphorylcholine and amphotericin b

Article	Year
Activities of hexadecylphosphocholine (miltefosine), AmBisome, and sodium stibogluconate (Pentostam) against Leishmania donovani in immunodeficient scid mice. Antimicrobial agents and chemotherapy, 2001, Volume: 45, Issue:6 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Leishmania donovani; Leishmaniasis, Visceral; Liver; Macrophages, Peritoneal; Mice; Mice, Inbred BALB C; Mice, SCID; Phosphorylcholine; Species Specificity	2001
Drug resistance in Indian visceral leishmaniasis. Tropical medicine & international health : TM & IH, 2001, Volume: 6, Issue:11 Topics: Aminoquinolines; Amphotericin B; Antimony; Antiprotozoal Agents; Dose-Response Relationship, Drug; Drug Resistance; Geography; History, 20th Century; History, 21st Century; Humans; India; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine; Treatment Outcome	2001
Sensitivities of Leishmania species to hexadecylphosphocholine (miltefosine), ET-18-OCH(3) (edelfosine) and amphotericin B. Acta tropica, 2002, Volume: 81, Issue:2 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Dose-Response Relationship, Drug; Leishmania; Macrophages, Peritoneal; Mice; Phospholipid Ethers; Phosphorylcholine; Species Specificity	2002
Miltefosine for Indian visceral leishmaniasis. The New England journal of medicine, 2003, Feb-27, Volume: 348, Issue:9 Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Research Design; Spleen; Suction	2003
The in vivo susceptibility of Leishmania donovani to sodium stibogluconate is drug specific and can be reversed by inhibiting glutathione biosynthesis. Antimicrobial agents and chemotherapy, 2003, Volume: 47, Issue:5 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Buthionine Sulfoximine; Drug Resistance; Female; Glutathione; Leishmania donovani; Leishmaniasis, Visceral; Male; Mice; Mice, Inbred BALB C; Paromomycin; Phosphorylcholine	2003
Development of a modified MTT assay for screening antimonial resistant field isolates of Indian visceral leishmaniasis. Parasitology international, 2005, Volume: 54, Issue:2 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Parasitic Sensitivity Tests; Phosphorylcholine; Tetrazolium Salts; Thiazoles	2005
Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models. Parasitology research, 2005, Volume: 96, Issue:4 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line; Cricetinae; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Resistance; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Male; Mesocricetus; Mice; Parasitic Diseases, Animal; Phosphorylcholine	2005
Challenges in the management of visceral leishmaniasis. Indian pediatrics, 2005, Volume: 42, Issue:6 Topics: Amebicides; Amphotericin B; Antimony Sodium Gluconate; Antiparasitic Agents; Antiprotozoal Agents; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Humans; Immunoglobulin G; Leishmaniasis, Visceral; Paromomycin; Pentamidine; Phosphorylcholine	2005
Successful treatment of post-kala-azar dermal leishmaniasis (PKDL) in a HIV infected patient with multiple relapsing leishmaniasis from Western Europe. The Journal of infection, 2006, Volume: 53, Issue:1 Topics: Adult; Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Europe; Germany; HIV Infections; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Male; Phosphorylcholine; Recurrence; Treatment Outcome	2006
Development of a semi-automated colorimetric assay for screening anti-leishmanial agents. Journal of microbiological methods, 2006, Volume: 66, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Colorimetry; Drug Evaluation, Preclinical; Humans; Indicators and Reagents; Inhibitory Concentration 50; Kinetics; Leishmania; Leishmania donovani; Leishmaniasis, Visceral; Pentamidine; Phosphorylcholine; Tetrazolium Salts; Thiazoles	2006
In vitro and in vivo interactions between miltefosine and other antileishmanial drugs. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cricetinae; Drug Synergism; Leishmania donovani; Leishmaniasis, Visceral; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Phosphorylcholine	2006
Interaction between miltefosine and amphotericin B: consequences for their activities towards intestinal epithelial cells and Leishmania donovani promastigotes in vitro. Antimicrobial agents and chemotherapy, 2006, Volume: 50, Issue:11 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Biological Transport, Active; Caco-2 Cells; Chromatography, High Pressure Liquid; Circular Dichroism; Drug Interactions; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Leishmania donovani; Phosphorylcholine; Spectrophotometry, Ultraviolet	2006
Drug policy for visceral leishmaniasis: a cost-effectiveness analysis. Tropical medicine & international health : TM & IH, 2007, Volume: 12, Issue:2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Cost-Benefit Analysis; Decision Trees; Deoxycholic Acid; Drug Combinations; Endemic Diseases; Health Care Costs; Humans; Leishmaniasis, Visceral; Phosphorylcholine; Treatment Outcome	2007
Glucantime-resistant Leishmania tropica isolated from Iranian patients with cutaneous leishmaniasis are sensitive to alternative antileishmania drugs. Parasitology research, 2007, Volume: 101, Issue:5 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Humans; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine	2007
Efficacy of pentavalent antimony, amphotericin B, and miltefosine in Leishmania amazonensis-infected macrophages under normoxic and hypoxic conditions. The Journal of parasitology, 2008, Volume: 94, Issue:6 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Hypoxia; Dose-Response Relationship, Drug; Inhibitory Concentration 50; Leishmania mexicana; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Organometallic Compounds; Oxygen; Phosphorylcholine	2008
Effect of therapeutic chemical agents in vitro and on experimental meningoencephalitis due to Naegleria fowleri. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:11 Topics: Amebiasis; Amebicides; Amphotericin B; Animals; Central Nervous System Protozoal Infections; Chlorpromazine; Female; In Vitro Techniques; Mice; Mice, Inbred BALB C; Naegleria fowleri; Parasitic Sensitivity Tests; Phosphorylcholine	2008
Isolation of Leishmania tropica from a patient with visceral leishmaniasis and disseminated cutaneous leishmaniasis, southern Iran. The American journal of tropical medicine and hygiene, 2008, Volume: 79, Issue:3 Topics: Adolescent; Amphotericin B; Animals; Antiprotozoal Agents; Female; Humans; Interferon-gamma; Iran; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Phosphorylcholine	2008
Leishmania infection can hamper immune recovery in virologically suppressed HIV-infected patients. The new microbiologica, 2008, Volume: 31, Issue:3 Topics: Adult; Amphotericin B; Anti-Retroviral Agents; Antiprotozoal Agents; CD4 Lymphocyte Count; HIV Infections; Humans; Leishmaniasis; Male; Phosphorylcholine	2008
Post-Kala-Azar dermal leishmaniasis in an HIV-1-infected woman: recovery after amphotericin B following failure of oral miltefosine. The American journal of tropical medicine and hygiene, 2008, Volume: 79, Issue:5 Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Antiparasitic Agents; Female; HIV-1; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Phosphorylcholine; Treatment Outcome	2008
In vitro susceptibility of field isolates of Leishmania donovani to Miltefosine and amphotericin B: correlation with sodium antimony gluconate susceptibility and implications for treatment in areas of endemicity. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:2 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; DNA Primers; Drug Resistance; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Phosphorylcholine; Reverse Transcriptase Polymerase Chain Reaction	2009
Anthropometrically derived dosing and drug costing calculations for treating visceral leishmaniasis in Bihar, India. Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:1 Topics: Adolescent; Adult; Age Distribution; Aged; Amphotericin B; Anthropometry; Antiprotozoal Agents; Body Weight; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Costs; Female; Humans; India; Infant; Leishmaniasis, Visceral; Liposomes; Male; Middle Aged; Paromomycin; Phosphorylcholine; Sex Distribution	2009
Cutaneous leishmaniasis with boggy induration and simultaneous mucosal disease. The American journal of tropical medicine and hygiene, 2009, Volume: 80, Issue:1 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Biopsy; Bolivia; Drug Therapy, Combination; Female; Humans; Leishmaniasis, Cutaneous; Middle Aged; Phosphorylcholine; Travel; Treatment Outcome	2009
Short report: Development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. The American journal of tropical medicine and hygiene, 2009, Volume: 80, Issue:3 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Dermatitis; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Middle Aged; Phosphorylcholine	2009
Newer strategies for the kala-azar elimination programme in India. The Indian journal of medical research, 2009, Volume: 129, Issue:1 Topics: Amphotericin B; Data Collection; Humans; India; Information Dissemination; Leishmaniasis, Visceral; Phosphorylcholine; Primary Prevention	2009
Highly effective oral amphotericin B formulation against murine visceral leishmaniasis. The Journal of infectious diseases, 2009, Aug-01, Volume: 200, Issue:3 Topics: Administration, Oral; Amphotericin B; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Dose-Response Relationship, Drug; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Parasitemia; Phosphorylcholine	2009
In vitro susceptibilities of Leishmania donovani promastigote and amastigote stages to antileishmanial reference drugs: practical relevance of stage-specific differences. Antimicrobial agents and chemotherapy, 2009, Volume: 53, Issue:9 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cells, Cultured; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Mice; Microscopy, Electron, Transmission; Parasitic Sensitivity Tests; Phosphorylcholine; Saponins; Triterpenes	2009
Cost-effectiveness projections of single and combination therapies for visceral leishmaniasis in Bihar, India. Tropical medicine & international health : TM & IH, 2009, Volume: 14, Issue:8 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Child; Cost-Benefit Analysis; Direct Service Costs; Drug Administration Schedule; Drug Costs; Female; Hospital Costs; Humans; India; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Practice Guidelines as Topic; Young Adult	2009
Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Annals of tropical medicine and parasitology, 2009, Volume: 103, Issue:8 Topics: Adult; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Biopsy; Female; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Middle Aged; Phosphorylcholine; Pregnancy; Treatment Outcome	2009
Selection and phenotype characterization of potassium antimony tartrate-resistant populations of four New World Leishmania species. Parasitology research, 2010, Volume: 107, Issue:1 Topics: Amphotericin B; Animals; Antimony Potassium Tartrate; Antiprotozoal Agents; Culture Media; Drug Resistance; Inhibitory Concentration 50; Leishmania; Leishmaniasis; Liver; Mice; Mice, Inbred C57BL; Mice, Knockout; Paromomycin; Phenotype; Phosphorylcholine; Selection, Genetic; Serial Passage; Spleen; Virulence	2010
Overexpression of histone H2A modulates drug susceptibility in Leishmania parasites. International journal of antimicrobial agents, 2010, Volume: 36, Issue:1 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Drug Resistance; Histones; Humans; India; Leishmania donovani; Mitogen-Activated Protein Kinase 1; Oligonucleotide Array Sequence Analysis; Phosphorylcholine; Protozoan Proteins	2010
Flow cytometric screening for anti-leishmanials in a human macrophage cell line. Experimental parasitology, 2010, Volume: 126, Issue:4 Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line; Cell Survival; Coloring Agents; Drug Evaluation, Preclinical; Flow Cytometry; Formazans; Humans; Leishmania mexicana; Macrophages; Phosphorylcholine; Tetrazolium Salts; Trypan Blue	2010
Cost-effectiveness analysis of combination therapies for visceral leishmaniasis in the Indian subcontinent. PLoS neglected tropical diseases, 2010, Sep-07, Volume: 4, Issue:9 Topics: Amphotericin B; Antiprotozoal Agents; Bangladesh; Cost-Benefit Analysis; Drug Therapy, Combination; Humans; India; Leishmaniasis, Visceral; Models, Statistical; Nepal; Paromomycin; Phosphorylcholine	2010
Treatment of visceral leishmaniasis in 2010: direction from Bihar State, India. Future microbiology, 2010, Volume: 5, Issue:9 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Paromomycin; Phosphorylcholine; Treatment Outcome	2010
Ambisome plus miltefosine for Indian patients with kala-azar. Transactions of the Royal Society of Tropical Medicine and Hygiene, 2011, Volume: 105, Issue:2 Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Drug Therapy, Combination; Female; Gastrointestinal Diseases; Humans; Infusions, Intravenous; Leishmaniasis, Visceral; Male; Middle Aged; Phosphorylcholine; Treatment Outcome; Young Adult	2011
A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis. The American journal of tropical medicine and hygiene, 2011, Volume: 84, Issue:1 Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Child; Female; Humans; Ketoconazole; Leishmania; Leishmaniasis, Cutaneous; Male; Middle Aged; Phosphorylcholine; Species Specificity	2011
Combination therapy for visceral leishmaniasis. Lancet (London, England), 2011, Feb-05, Volume: 377, Issue:9764 Topics: Amphotericin B; Antiprotozoal Agents; Drug Administration Schedule; Drug Therapy, Combination; Humans; India; Leishmaniasis, Visceral; Paromomycin; Phosphorylcholine; Randomized Controlled Trials as Topic	2011
Mucosal Leishmania infantum infection. Parasitology research, 2011, Volume: 109, Issue:3 Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Esophagus; Europe; Female; Humans; Leishmania infantum; Leishmaniasis, Mucocutaneous; Male; Middle Aged; Mouth Mucosa; Nasal Mucosa; Phosphorylcholine; Treatment Outcome	2011
A rare case of Visceral leishmaniasis with multiple relapse and multi-drug unresponsive: successfully treated with combination therapy. International journal of clinical pharmacy, 2011, Volume: 33, Issue:5 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Leishmaniasis, Visceral; Male; Phosphorylcholine; Recurrence	2011
Tolerance to drug-induced cell death favours the acquisition of multidrug resistance in Leishmania. Cell death & disease, 2011, Sep-01, Volume: 2 Topics: Amphotericin B; Antimony; Antiprotozoal Agents; Apoptosis; Cell Death; Drug Resistance, Multiple; Drug Tolerance; Leishmania infantum; Methotrexate; Paromomycin; Phosphorylcholine; Reactive Oxygen Species	2011
Treatment of imported New World cutaneous leishmaniasis in Germany. International journal of dermatology, 2011, Volume: 50, Issue:11 Topics: Adolescent; Adult; Aged; Amphotericin B; Animals; Antiprotozoal Agents; Female; Germany; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Meglumine; Meglumine Antimoniate; Middle Aged; Organometallic Compounds; Phosphorylcholine; Travel; Young Adult	2011
Leishmania resistance to miltefosine associated with genetic marker. Emerging infectious diseases, 2012, Volume: 18, Issue:4 Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Female; Humans; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis, Visceral; Maintenance Chemotherapy; Middle Aged; Phosphorylcholine; Recurrence	2012
Development of splenic marginal zone lymphoma in a HIV-negative patient with visceral leishmaniasis. Acta haematologica, 2012, Volume: 128, Issue:1 Topics: Amphotericin B; Antiprotozoal Agents; Bone Marrow; HIV; HIV Infections; Humans; Immunophenotyping; Kidney; Leishmania infantum; Leishmaniasis, Visceral; Liver; Lymphoma, B-Cell, Marginal Zone; Macrophages; Male; Middle Aged; Multimodal Imaging; Phosphorylcholine; Positron-Emission Tomography; Splenic Neoplasms; Tomography, X-Ray Computed	2012
Limited activity of miltefosine in murine models of cryptococcal meningoencephalitis and disseminated cryptococcosis. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:2 Topics: Amphotericin B; Animals; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Deoxycholic Acid; Drug Combinations; Fluconazole; Meningitis, Cryptococcal; Meningoencephalitis; Mice; Microbial Sensitivity Tests; Phosphorylcholine; Survival	2013
A series of case reports of autochthonous visceral leishmaniasis, mostly in non-endemic hilly areas of Nepal. The American journal of tropical medicine and hygiene, 2013, Volume: 88, Issue:2 Topics: Adolescent; Adult; Aged; Amphotericin B; Child; Child, Preschool; Dose-Response Relationship, Drug; Humans; Leishmania; Leishmaniasis, Visceral; Male; Middle Aged; Nepal; Phosphorylcholine; Young Adult	2013
Apoptotic marker expression in the absence of cell death in staurosporine-treated Leishmania donovani. Antimicrobial agents and chemotherapy, 2013, Volume: 57, Issue:3 Topics: Amino Acid Sequence; Amphotericin B; Annexin A5; Antiprotozoal Agents; Apoptosis; Benzamides; Biomarkers; Casein Kinase I; Cell Cycle Checkpoints; Humans; Imidazoles; Leishmania donovani; Molecular Sequence Data; Phosphorylcholine; Phosphotransferases; Protein Biosynthesis; Protein Kinase Inhibitors; Protozoan Proteins; Staurosporine; Substrate Specificity	2013
Susceptibility of clinical isolates of Leishmania aethiopica to miltefosine, paromomycin, amphotericin B and sodium stibogluconate using amastigote-macrophage in vitro model. Experimental parasitology, 2013, Volume: 134, Issue:1 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Cells, Cultured; Ethiopia; Humans; Inhibitory Concentration 50; Leishmania; Leishmaniasis, Cutaneous; Macrophages, Peritoneal; Mice; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine	2013
Interactions of antileishmanial drugs with monolayers of lipids used in the development of amphotericin B-miltefosine-loaded nanocochleates. Colloids and surfaces. B, Biointerfaces, 2013, Jun-01, Volume: 106 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Leishmania; Nanostructures; Phosphorylcholine	2013
Retrospective Quarterly Cohort Monitoring for patients with Visceral Leishmaniasis in the Indian subcontinent: outcomes of a pilot project. Tropical medicine & international health : TM & IH, 2013, Volume: 18, Issue:6 Topics: Amphotericin B; Antiprotozoal Agents; Cohort Studies; Data Collection; Female; Humans; India; Leishmaniasis, Visceral; Male; Nepal; Phosphorylcholine; Pilot Projects; Primary Health Care; Retrospective Studies; Time Factors; Treatment Outcome	2013
Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers. European journal of dermatology : EJD, 2013, Apr-01, Volume: 23, Issue:2 Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmaniasis, Cutaneous; Male; Phosphorylcholine; South America; Travel; Young Adult	2013
Comment on: leishmaniasis: an update of current pharmacotherapy. Expert opinion on pharmacotherapy, 2013, Volume: 14, Issue:9 Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Organometallic Compounds; Paromomycin; Phosphorylcholine	2013
In vitro drug susceptibility of Leishmania infantum isolated from humans and dogs. Experimental parasitology, 2013, Volume: 135, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Deoxycholic Acid; Disease Reservoirs; Dog Diseases; Dogs; Drug Combinations; Humans; Immunocompetence; Immunocompromised Host; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Meglumine; Meglumine Antimoniate; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine	2013
Drug resistance in natural isolates of Leishmania donovani s.l. promastigotes is dependent of Pgp170 expression. PloS one, 2013, Volume: 8, Issue:6 Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Leishmania donovani; Meglumine; Meglumine Antimoniate; Membrane Proteins; Organometallic Compounds; Phosphorylcholine; Protozoan Proteins; Rhodamine 123	2013
Combination therapy with amphotericin-B and miltefosine for post-kala-azar dermal leishmaniasis: a preliminary report. Acta dermato-venereologica, 2014, Volume: 94, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; DNA, Protozoan; Drug Therapy, Combination; Humans; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Parasite Load; Phosphorylcholine; Young Adult	2014
Combination therapy with nitazoxanide and amphotericin B, Glucantime®, miltefosine and sitamaquine against Leishmania (Leishmania) infantum intracellular amastigotes. Acta tropica, 2014, Volume: 130 Topics: Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Combinations; Leishmania infantum; Leishmaniasis, Visceral; Macrophages, Peritoneal; Meglumine; Meglumine Antimoniate; Mice; Nitro Compounds; Organometallic Compounds; Parasitic Sensitivity Tests; Phosphorylcholine; Thiazoles	2014
Multiple relapses of visceral leishmaniasis in a patient with HIV in India: a treatment challenge. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases, 2014, Volume: 25 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Antiretroviral Therapy, Highly Active; Coinfection; HIV Infections; Humans; India; Leishmaniasis, Visceral; Male; Phosphorylcholine; Recurrence; Treatment Outcome	2014
Development of antileishmanial lipid nanocomplexes. Biochimie, 2014, Volume: 107 Pt A Topics: Administration, Oral; Amphotericin B; Antiprotozoal Agents; Calcium; Cholesterol; Circular Dichroism; Drug Compounding; Drug Stability; Humans; Leishmaniasis, Visceral; Lipids; Liposomes; Microscopy, Electron, Transmission; Nanocomposites; Particle Size; Phosphatidylserines; Phosphorylcholine; Spectrophotometry	2014
The overexpression of genes of thiol metabolism contribute to drug resistance in clinical isolates of visceral leishmaniasis (kala azar) in India. Parasites & vectors, 2014, Dec-17, Volume: 7 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Drug Resistance; Glutamate-Cysteine Ligase; Humans; India; Leishmania donovani; Leishmaniasis, Visceral; Membrane Transport Proteins; Mutation; Phosphorylcholine; Protozoan Proteins; Sulfhydryl Compounds	2014
Using a non-image-based medium-throughput assay for screening compounds targeting N-myristoylation in intracellular Leishmania amastigotes. PLoS neglected tropical diseases, 2014, Volume: 8, Issue:12 Topics: Acyltransferases; Amphotericin B; Animals; Antiprotozoal Agents; Drug Evaluation, Preclinical; Enzyme Inhibitors; Female; Humans; Leishmania donovani; Macrophages; Mice; Mice, Inbred BALB C; Phosphorylcholine	2014
In vitro activity of miltefosine in combination with voriconazole or amphotericin B against clinical isolates of Scedosporium spp. Journal of medical microbiology, 2015, Volume: 64, Issue:Pt 3 Topics: Amphotericin B; Antifungal Agents; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Mycoses; Phosphorylcholine; Scedosporium; Voriconazole	2015
Miltefosine is active against Sporothrix brasiliensis isolates with in vitro low susceptibility to amphotericin B or itraconazole. Journal of medical microbiology, 2015, Volume: 64, Issue:Pt 4 Topics: Amphotericin B; Animals; Antifungal Agents; Brazil; Cell Line; Cell Membrane; Cell Survival; Cell Wall; Cytoplasm; Drug Resistance, Fungal; Epithelial Cells; Humans; Itraconazole; Macaca mulatta; Microbial Sensitivity Tests; Microbial Viability; Microscopy, Electron, Transmission; Phosphorylcholine; Sporothrix; Sporotrichosis	2015
Combination Treatment for Visceral Leishmaniasis Patients Coinfected with Human Immunodeficiency Virus in India. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2015, Oct-15, Volume: 61, Issue:8 Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Amphotericin B; Coinfection; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; HIV Infections; Humans; India; Leishmaniasis, Visceral; Male; Middle Aged; Phosphorylcholine; Recurrence; Retrospective Studies; Risk Factors; Treatment Failure; Treatment Outcome; Young Adult	2015
A male preponderance in patients with Indian post kala-azar dermal leishmaniasis is associated with increased circulating levels of testosterone. International journal of dermatology, 2016, Volume: 55, Issue:5 Topics: Adolescent; Adult; Amphotericin B; Antibodies, Protozoan; Antimony Sodium Gluconate; Antiprotozoal Agents; Disease Progression; Female; Humans; Immunoglobulin G; India; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Neglected Diseases; Phosphorylcholine; Sex Factors; Testosterone; Young Adult	2016
15d-Prostaglandin J2 induced reactive oxygen species-mediated apoptosis during experimental visceral leishmaniasis. Journal of molecular medicine (Berlin, Germany), 2016, Volume: 94, Issue:6 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Apoptosis; Cell Line; Cricetulus; Disease Models, Animal; Drug Administration Schedule; Female; Interleukin-10; Leishmania donovani; Leishmaniasis, Visceral; Life Cycle Stages; Liver; Macrophages; Male; Mice; Mice, Inbred BALB C; Mitochondria; Phosphorylcholine; Prostaglandin D2; Reactive Oxygen Species; Spleen; Transforming Growth Factor beta; Treatment Outcome	2016
Treatment of visceral leishmaniasis: options and choice. The Lancet. Infectious diseases, 2016, Volume: 16, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Humans; Leishmaniasis, Visceral; Phosphorylcholine	2016
Naegleria fowleri That Induces Primary Amoebic Meningoencephalitis: Rapid Diagnosis and Rare Case of Survival in a 12-Year-Old Caucasian Girl. Laboratory medicine, 2016, Volume: 47, Issue:2 Topics: Amebiasis; Amphotericin B; Antiprotozoal Agents; Azithromycin; Central Nervous System Protozoal Infections; Cerebrospinal Fluid; Cerebrospinal Fluid Shunts; Child; Early Diagnosis; Female; Fluconazole; Humans; Hypothermia, Induced; Meningoencephalitis; Naegleria fowleri; Phosphorylcholine; Rifampin	2016
A Replicative In Vitro Assay for Drug Discovery against Leishmania donovani. Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; Female; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Phosphorylcholine	2016
A Luciferase-Expressing Leishmania braziliensis Line That Leads to Sustained Skin Lesions in BALB/c Mice and Allows Monitoring of Miltefosine Treatment Outcome. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:5 Topics: Amphotericin B; Animals; Antifungal Agents; Antiprotozoal Agents; Cricetinae; Deoxycholic Acid; Drug Combinations; Female; Gene Expression Regulation, Enzymologic; Leishmania braziliensis; Leishmaniasis, Cutaneous; Luciferases; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Organisms, Genetically Modified; Phosphorylcholine; Time Factors	2016
Experience with miltefosine for persistent or relapsing visceral leishmaniasis in solid organ transplant recipients: A case series from Spain. Transplant infectious disease : an official journal of the Transplantation Society, 2017, Volume: 19, Issue:1 Topics: Adult; Aged; Amphotericin B; Antiprotozoal Agents; Humans; Immunocompromised Host; Incidence; Kidney Transplantation; Leishmania infantum; Leishmaniasis, Visceral; Lung Transplantation; Male; Middle Aged; Phosphorylcholine; Retrospective Studies; Salvage Therapy; Secondary Prevention; Spain; Treatment Outcome	2017
Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms. PLoS neglected tropical diseases, 2016, Volume: 10, Issue:12 Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis; Mutation; Phosphorylcholine; Proton-Translocating ATPases; Protozoan Proteins	2016
Study of antileishmanial activity of 2-aminobenzoyl amino acid hydrazides and their quinazoline derivatives. Bioorganic & medicinal chemistry letters, 2017, 02-15, Volume: 27, Issue:4 Topics: Amino Acids; Amphotericin B; Antiprotozoal Agents; Deoxycholic Acid; Drug Combinations; Inhibitory Concentration 50; Isomerism; Leishmania; Magnetic Resonance Spectroscopy; Molecular Conformation; Phosphorylcholine; Quinazolines; Structure-Activity Relationship	2017
Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine. PLoS neglected tropical diseases, 2017, Volume: 11, Issue:5 Topics: Amphotericin B; Antiprotozoal Agents; Cell Line, Tumor; Drug Evaluation, Preclinical; Humans; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Phosphorylcholine	2017
Efficacy of Paromomycin-Chloroquine Combination Therapy in Experimental Cutaneous Leishmaniasis. Antimicrobial agents and chemotherapy, 2017, Volume: 61, Issue:8 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Chloroquine; Disease Models, Animal; Drug Combinations; Female; Leishmania major; Leishmania mexicana; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Parasite Load; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine	2017
Recurrence of visceral and muco-cutaneous leishmaniasis in a patient under immunosuppressive therapy. BMC infectious diseases, 2017, 07-07, Volume: 17, Issue:1 Topics: Amphotericin B; Antiprotozoal Agents; Biopsy; Female; Humans; Immunocompromised Host; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages; Middle Aged; Paromomycin; Phosphorylcholine; Polymerase Chain Reaction; Recurrence	2017
Hexadecylphosphocholine (Miltefosine) stabilized chitosan modified Ampholipospheres as prototype co-delivery vehicle for enhanced killing of L. donovani. International journal of biological macromolecules, 2017, Volume: 105, Issue:Pt 1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Chitosan; Drug Carriers; Drug Stability; Leishmania donovani; Macrophages; Nanoparticles; Phosphorylcholine; Rats; Rats, Wistar; Tissue Distribution	2017
Monitoring of Parasite Kinetics in Indian Post-Kala-azar Dermal Leishmaniasis. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2018, 01-18, Volume: 66, Issue:3 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Asymptomatic Infections; Biopsy; DNA, Intergenic; DNA, Protozoan; Female; Humans; India; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Parasite Load; Phosphorylcholine; Polymerase Chain Reaction; Skin; Young Adult	2018
Synthesis, modeling and biological evaluation of hybrids from pyrazolo[1,5c]pyrimidine as antileishmanial agents. Future medicinal chemistry, 2017, Volume: 9, Issue:16 Topics: Amphotericin B; Antiprotozoal Agents; Binding Sites; Deoxycholic Acid; Drug Combinations; Drug Design; Humans; Leishmania major; Molecular Docking Simulation; Molecular Structure; Phosphorylcholine; Protein Binding; Pyrazoles; Pyrimidines; Structure-Activity Relationship	2017
Miltefosine-resistant Leishmania infantum strains with an impaired MT/ROS3 transporter complex retain amphotericin B susceptibility. The Journal of antimicrobial chemotherapy, 2018, 02-01, Volume: 73, Issue:2 Topics: Amphotericin B; Antiprotozoal Agents; Drug Resistance; Humans; Leishmania infantum; Leishmaniasis, Visceral; Membrane Transport Proteins; Mutant Proteins; Parasitic Sensitivity Tests; Phosphorylcholine; Protozoan Proteins	2018
In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species. Experimental parasitology, 2018, Volume: 184 Topics: Amino Acid Sequence; Amphotericin B; Animals; Antiprotozoal Agents; Arginase; Benzimidazoles; Cell Line; Inhibitory Concentration 50; Leishmania braziliensis; Leishmania donovani; Leishmania mexicana; Leishmaniasis, Cutaneous; Leishmaniasis, Mucocutaneous; Leishmaniasis, Visceral; Macrophages; Mice; Molecular Docking Simulation; Phosphorylcholine; Sequence Alignment	2018
Successful Treatment of Disseminated Cutaneous Leishmaniasis With Liposomal Amphotericin B and Miltefosine in an Eight-year-old Girl. The Pediatric infectious disease journal, 2018, Volume: 37, Issue:3 Topics: Amphotericin B; Antiprotozoal Agents; Child; Female; Humans; Iran; Leishmaniasis, Cutaneous; Phosphorylcholine; Skin; Treatment Outcome	2018
Pharmacodynamics and cellular accumulation of amphotericin B and miltefosine in Leishmania donovani-infected primary macrophages. The Journal of antimicrobial chemotherapy, 2018, 05-01, Volume: 73, Issue:5 Topics: Amphotericin B; Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Cells, Cultured; Female; Leishmania donovani; Macrophages; Mice, Inbred BALB C; Models, Theoretical; Phosphorylcholine	2018
High-throughput Cos-Seq screen with intracellular Leishmania infantum for the discovery of novel drug-resistance mechanisms. International journal for parasitology. Drugs and drug resistance, 2018, Volume: 8, Issue:2 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cosmids; CRISPR-Cas Systems; Drug Resistance; Gene Library; High-Throughput Nucleotide Sequencing; Leishmania infantum; Leishmaniasis; Life Cycle Stages; Macrophages; Phosphorylcholine	2018
In vitro 4-Aryloxy-7-chloroquinoline derivatives are effective in mono- and combined therapy against Leishmania donovani and induce mitocondrial membrane potential disruption. Acta tropica, 2018, Volume: 183 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Drug Therapy, Combination; Leishmania donovani; Macrophages; Membrane Potential, Mitochondrial; Mice; Phosphorylcholine; Quinolines	2018
Lactoferrin-modified Betulinic Acid-loaded PLGA nanoparticles are strong anti-leishmanials. Cytokine, 2018, Volume: 110 Topics: Amphotericin B; Animals; Anti-Inflammatory Agents; Antiparasitic Agents; Betulinic Acid; Cytokines; Lactoferrin; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Nanoparticles; Pentacyclic Triterpenes; Phosphorylcholine; Polylactic Acid-Polyglycolic Acid Copolymer; Triterpenes	2018
The initial effectiveness of liposomal amphotericin B (AmBisome) and miltefosine combination for treatment of visceral leishmaniasis in HIV co-infected patients in Ethiopia: A retrospective cohort study. PLoS neglected tropical diseases, 2018, Volume: 12, Issue:5 Topics: Adult; Amphotericin B; Antiprotozoal Agents; Coinfection; Drug Therapy, Combination; Ethiopia; Female; HIV Infections; Humans; Leishmaniasis, Visceral; Male; Middle Aged; Phosphorylcholine; Retrospective Studies; Treatment Outcome; Young Adult	2018
Miltefosine Has a Postantifungal Effect and Induces Apoptosis in Cryptococcus Yeasts. Antimicrobial agents and chemotherapy, 2018, Volume: 62, Issue:8 Topics: Amphotericin B; Antifungal Agents; Apoptosis; Biofilms; Cell Membrane; Cell Membrane Permeability; Cryptococcosis; Cryptococcus gattii; Cryptococcus neoformans; DNA Fragmentation; Ergosterol; Fungal Capsules; Humans; Membrane Potential, Mitochondrial; Microbial Sensitivity Tests; Opportunistic Infections; Phosphorylcholine; Plankton; Reactive Oxygen Species	2018
Potentiation of the leishmanicidal activity of nelfinavir in combination with miltefosine or amphotericin B. International journal of antimicrobial agents, 2018, Volume: 52, Issue:5 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Survival; Disease Models, Animal; Drug Synergism; Humans; Leishmania infantum; Leishmaniasis, Visceral; Liver; Male; Mice, Inbred BALB C; Nelfinavir; Parasite Load; Phosphorylcholine; Spleen; Treatment Outcome	2018
Effect of Anti-Leishmania Drugs on the Structural and Elastic Properties of Ultradeformable Lipid Membranes. The journal of physical chemistry. B, 2018, 07-26, Volume: 122, Issue:29 Topics: Amphotericin B; Antiprotozoal Agents; Imiquimod; Indoles; Liposomes; Phosphatidylcholines; Phosphorylcholine; Sodium Cholate; X-Ray Diffraction	2018
Using focused pharmacovigilance for ensuring patient safety against antileishmanial drugs in Bangladesh's National Kala-azar Elimination Programme. Infectious diseases of poverty, 2018, Aug-13, Volume: 7, Issue:1 Topics: Acute Kidney Injury; Adolescent; Adult; Aged; Amphotericin B; Antiprotozoal Agents; Bangladesh; Female; Humans; Leishmania donovani; Leishmania tropica; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Male; Middle Aged; Myocardial Infarction; Paromomycin; Patient Safety; Pharmacovigilance; Phosphorylcholine; Quality of Life; Recurrence; Survival Analysis	2018
Impact of primary mouse macrophage cell types on Leishmania infection and in vitro drug susceptibility. Parasitology research, 2018, Volume: 117, Issue:11 Topics: Amphotericin B; Animals; Antimony; Antiprotozoal Agents; Cells, Cultured; Drug Resistance; Female; Interleukin-6; Leishmania infantum; Leishmaniasis; Macrophages; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nitric Oxide; Parasitic Sensitivity Tests; Paromomycin; Phosphorylcholine; Reactive Oxygen Species; Tumor Necrosis Factor-alpha	2018
Eliminating visceral leishmaniasis in South Asia: the road ahead. BMJ (Clinical research ed.), 2019, Jan-22, Volume: 364 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Bangladesh; Disease Vectors; Drug Therapy, Combination; Epidemiological Monitoring; Humans; India; International Cooperation; Leishmaniasis, Visceral; Neglected Diseases; Nepal; Paromomycin; Phosphorylcholine; Program Development; Program Evaluation	2019
Chemogenomic Profiling of Antileishmanial Efficacy and Resistance in the Related Kinetoplastid Parasite Trypanosoma brucei. Antimicrobial agents and chemotherapy, 2019, Volume: 63, Issue:8 Topics: Adenosine Triphosphatases; Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Leishmania; Paromomycin; Phosphorylcholine; R-SNARE Proteins; Trypanosoma brucei brucei	2019
Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani. International journal for parasitology. Drugs and drug resistance, 2019, Volume: 10 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Synergism; Drug Therapy, Combination; Host-Parasite Interactions; Humans; Leishmania donovani; Leishmaniasis, Visceral; Life Cycle Stages; Mice; Mice, Inbred BALB C; Phosphorylcholine; Pyrazoles; Sulfonamides	2019
Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India. PLoS neglected tropical diseases, 2019, Volume: 13, Issue:9 Topics: Adolescent; Amphotericin B; Antiprotozoal Agents; Child; Child, Preschool; Cohort Studies; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; India; Leishmaniasis, Visceral; Male; Paromomycin; Phosphorylcholine; Recurrence; Treatment Outcome	2019
Topical treatment of cutaneous leishmaniasis with novel amphotericin B-miltefosine co-incorporated second generation ultra-deformable liposomes. International journal of pharmaceutics, 2020, Jan-05, Volume: 573 Topics: Administration, Cutaneous; Amphotericin B; Animals; Antiprotozoal Agents; Disease Models, Animal; Drug Combinations; Drug Compounding; Elasticity; Female; Humans; Inhibitory Concentration 50; Leishmania; Leishmaniasis, Cutaneous; Liposomes; Mice; Nanoparticles; Parasite Load; Particle Size; Permeability; Phosphorylcholine; Skin	2020
Cutaneous leishmaniasis with secondary mucosal disease in a traveller due to Leishmania (Viannia) braziliensis. Journal of travel medicine, 2020, Feb-03, Volume: 27, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Communicable Diseases, Imported; Ear; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Middle Aged; Phosphorylcholine; Travel	2020
Antimicrobial agents and chemotherapy, 2020, 01-27, Volume: 64, Issue:2 Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Multiple; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Phosphorylcholine	2020
Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis. The Journal of infectious diseases, 2020, 02-03, Volume: 221, Issue:4 Topics: Adolescent; Adult; Amphotericin B; Antiprotozoal Agents; Child; DNA, Protozoan; Drug Therapy, Combination; Female; Humans; Leishmania donovani; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liposomes; Longitudinal Studies; Male; Middle Aged; Parasite Load; Phosphorylcholine; Real-Time Polymerase Chain Reaction; Recurrence; Treatment Outcome; Young Adult	2020
Comparison of Turkiye parazitolojii dergisi, 2020, Mar-20, Volume: 44, Issue:1 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; Drug Resistance; Female; Genotyping Techniques; Humans; Leishmania; Leishmaniasis, Cutaneous; Male; Meglumine Antimoniate; Paromomycin; Phosphorylcholine; Real-Time Polymerase Chain Reaction; Turkey	2020
Case Report: Mucosal Leishmaniasis in New York City. The American journal of tropical medicine and hygiene, 2020, Volume: 102, Issue:6 Topics: Aged; Amphotericin B; Antiprotozoal Agents; Humans; Leishmania braziliensis; Leishmaniasis, Mucocutaneous; Male; Middle Aged; New York City; Phosphorylcholine	2020
Modified solid lipid nanoparticles encapsulated with Amphotericin B and Paromomycin: an effective oral combination against experimental murine visceral leishmaniasis. Scientific reports, 2020, 07-22, Volume: 10, Issue:1 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Cell Line; Emulsions; Leishmania donovani; Leishmaniasis, Visceral; Lipids; Male; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Nanoparticles; Paromomycin; Particle Size; Phosphorylcholine	2020
Persistent dermal lesions in a patient with previous history of visceral leishmaniasis. Parasitology international, 2021, Volume: 80 Topics: Albania; Amphotericin B; Antiprotozoal Agents; Fatal Outcome; Humans; Leishmania infantum; Leishmaniasis, Visceral; Male; Phosphorylcholine; Recurrence; Skin Diseases, Parasitic; Turkey; Young Adult	2021
The drug resistance mechanisms in Leishmania donovani are independent of immunosuppression. Cytokine, 2021, Volume: 145 Topics: Amphotericin B; Animals; Antimony; Cytokines; Drug Resistance; Immunosuppression Therapy; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice; Mice, Inbred BALB C; Phosphorylcholine; Protozoan Proteins	2021
Scientometric analysis of chemotherapy of canine leishmaniasis (2000-2020). Parasites & vectors, 2021, Jan-09, Volume: 14, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Combinations; Drug Therapy; Humans; Leishmania infantum; Leishmaniasis; Leishmaniasis, Visceral; Phosphorylcholine; Publications	2021
Pharmacokinetic / pharmacodynamic relationships of liposomal amphotericin B and miltefosine in experimental visceral leishmaniasis. PLoS neglected tropical diseases, 2021, Volume: 15, Issue:3 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Drug Therapy, Combination; Homeodomain Proteins; Humans; Leishmaniasis, Visceral; Liver; Male; Mice; Mice, Inbred BALB C; Mice, Knockout; Parasite Load; Phosphorylcholine; Protein Binding	2021
Investigating the Aggregation of Imported Cutaneous Leishmaniasis in Henan, Central China. Biomedical and environmental sciences : BES, 2021, Mar-20, Volume: 34, Issue:3 Topics: Amphotericin B; Animals; Antimony Sodium Gluconate; Antiprotozoal Agents; China; Communicable Diseases, Imported; DNA, Kinetoplast; Humans; Leishmaniasis, Cutaneous; Phosphorylcholine; Psychodidae	2021
Comparative EPR spectroscopy analysis of amphotericin B and miltefosine interactions with Leishmania, erythrocyte and macrophage membranes. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences, 2021, Aug-01, Volume: 163 Topics: Amphotericin B; Animals; Antiprotozoal Agents; Electron Spin Resonance Spectroscopy; Erythrocytes; Humans; Leishmania; Macrophages; Mice; Phosphorylcholine	2021
Case Report: Progressive Dysphonia and Dysphagia due to Laryngeal Leishmaniasis. The American journal of tropical medicine and hygiene, 2021, 06-14, Volume: 105, Issue:2 Topics: Aged; Amphotericin B; Antiprotozoal Agents; Deglutition Disorders; Diagnosis, Differential; Dysphonia; Humans; Laryngeal Neoplasms; Larynx; Leishmaniasis; Male; Phosphorylcholine	2021
Increased Leishmania infantum resistance to miltefosine and amphotericin B after treatment of a dog with miltefosine and allopurinol. Parasites & vectors, 2021, Dec-09, Volume: 14, Issue:1 Topics: Allopurinol; Amphotericin B; Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Drug Resistance; Female; Leishmania infantum; Leishmaniasis, Visceral; Meglumine Antimoniate; Phosphorylcholine	2021
Mycobacterium abscessus cell wall and plasma membrane characterization by EPR spectroscopy and effects of amphotericin B, miltefosine and nerolidol. Biochimica et biophysica acta. Biomembranes, 2022, 05-01, Volume: 1864, Issue:5 Topics: Amphotericin B; Anti-Bacterial Agents; Cell Membrane; Cell Wall; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Microbial Sensitivity Tests; Mycobacterium abscessus; Phosphatidylcholines; Phosphorylcholine; Sesquiterpenes; Spin Labels; Stearic Acids	2022
Leishmania amazonensis from distinct clinical forms/hosts has polymorphisms in Lipophosphoglycans, displays variations in immunomodulatory properties and, susceptibility to antileishmanial drugs. Cell biology international, 2022, Volume: 46, Issue:11 Topics: Amphotericin B; Animals; Dogs; Glycosphingolipids; Interleukin-6; Leishmania; Meglumine Antimoniate; Mice; Mice, Inbred BALB C; Phosphorylcholine; Tumor Necrosis Factor-alpha	2022
In vitro miltefosine and amphotericin B susceptibility of strains and clinical isolates of Leishmania species endemic in Brazil that cause tegumentary leishmaniasis. Experimental parasitology, 2023, Volume: 246 Topics: Amphotericin B; Antiprotozoal Agents; Brazil; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Cutaneous; Phosphorylcholine	2023
C-reactive protein interacts with amphotericin B liposomes and its potential clinical consequences. Clinical chemistry and laboratory medicine, 2023, 05-25, Volume: 61, Issue:6 Topics: Amphotericin B; Antifungal Agents; C-Reactive Protein; Humans; Liposomes; Phosphorylcholine	2023
In vitro susceptibility to miltefosine of amphotericin B-resistant Leishmania (Mundinia) martiniquensis. Parasitology research, 2023, Volume: 122, Issue:12 Topics: Amphotericin B; Antiprotozoal Agents; Chronic Disease; Humans; Leishmania; Leishmaniasis; Leishmaniasis, Visceral; Phosphorylcholine; Recurrence	2023